Photo: Pixabay
Healthcare-focused private equity firm InvAscent has secured $115.6 million so far for its latest life sciences fund from US-based investors, according to a filing with the Securities and Exchange Commission (SEC).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Subscribe now
Printed by Unregistered user on Wed, 26 Jun 2024 11:50:06 GMT
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : DealStreetAsia – https://www.dealstreetasia.com/stories/invascent-india-life-sciences-fund-iv-401340/
